Functional characterisation of a mouse model of DOK7 congenital myasthenic syndrome and response to treatment with salbutamol

被引:0
|
作者
Webster, R. G. [1 ]
Vanhaesebrouck, A. E. [1 ]
Maxwell, S. E. [1 ]
Cossins, J. A. [1 ]
Beeson, D. M. W. [1 ]
机构
[1] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England
关键词
D O I
10.1016/S0960-8966(18)30368-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
NMJ C01
引用
收藏
页码:S26 / S27
页数:2
相关论文
共 50 条
  • [41] Positive response to inhaled salbutamol in congenital myasthenic syndrome due to CHRNE mutation
    Garg, Divyani
    Goyal, Vinay
    MUSCLE & NERVE, 2022, 66 (01) : E1 - E2
  • [42] Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
    McMacken, Grace M.
    Spendiff, Sally
    Whittaker, Roger G.
    O'Connor, Emily
    Howarth, Rachel M.
    Boczonadi, Veronika
    Horvath, Rita
    Slater, Clarke R.
    Lochmuller, Hanns
    HUMAN MOLECULAR GENETICS, 2019, 28 (14) : 2339 - 2351
  • [43] The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
    Beeson, D.
    Cossins, J.
    Maxwell, S.
    Liu, W-W.
    Oldridge, M.
    Finlayson, S.
    Robb, S.
    Palace, J.
    NEUROMUSCULAR DISORDERS, 2012, 22 : S16 - S16
  • [44] Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction
    Maselli, Ricardo A.
    Arredondo, Juan
    Cagney, Orla
    Ng, Jarae J.
    Anderson, Jennifer A.
    Williams, Colette
    Gerke, Bae J.
    Soliven, Betty
    Wollmann, Robert L.
    HUMAN MOLECULAR GENETICS, 2010, 19 (12) : 2370 - 2379
  • [45] Late-onset and milder phenotypes in a DOK7 myasthenic syndrome cohort to rethink the natural history of a perceived severe disease
    Brisson, J.
    Villeneuve, J.
    Nicolas, L.
    Mathieu, J.
    Gagnon, C.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [46] Late presentation DOK7 congenital myasthenia syndrome (CMS), misdiagnosed as myasthenia gravis (MG)- a case series
    Henehan, L.
    Rossini, E.
    Dong, Y.
    Beeson, D.
    Ramdas, S.
    Leite, I.
    Palace, J.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [47] Dramatic improvement of scoliosis in a patient with DOK7-related congenital myasthenic syndrome treated with ephedrine
    Graca, F.
    Iwabe, C.
    Cavalcante Franca, M., Jr.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S113 - S113
  • [48] CHARACTERISATION OF A NOVEL MOUSE MODEL FOR CONGENITAL MYASTHENIC SYNDROME DUE TO DEFECTIVE ACHR CLUSTERING CAUSED BY MUTATIONS IN CHRND
    Alabaf, Setareh
    Webster, Richard G.
    Liu, W. W.
    Cossins, Judith
    Beeson, David
    Dong, Yin
    MUSCLE & NERVE, 2022, 65 : S25 - S25
  • [49] AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
    Spillane, J.
    Kullmann, D. M.
    Beeson, D.
    Howard, R. S.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (03):
  • [50] A GFPT1 deficient mouse model of congenital myasthenic syndrome
    Issop, Y.
    Laval, S. H.
    Lochmueller, H.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S33 - S33